Improved and semi-automated GMP-compliant radiosynthesis of [11C]docetaxel

Applied Radiation and Isotopes

Volumn 66, Issue 10, 2008, Pages 1414-1418

  van Tilburg, E W ^a   Mooijer, M P J ^a   Brinkhorst, J ^a   van der Meij, M ^a   Windhorst, A D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

11C Docetaxel; 11C tert butanol ( 2 11C 2 methylpropan 2 ol); GMP compliant; Positron emission tomography (PET); Tert butoxycarbonylation

Indexed keywords

[11C]DOCETAXEL; [11C]TERT-BUTANOL ([2-11C]2-METHYLPROPAN-2-OL); GMP-COMPLIANT; POSITRON EMISSION TOMOGRAPHY (PET); RADIOSYNTHESIS; SEMI-AUTOMATED; TERT-BUTOXYCARBONYLATION;

1,2,2,2 TETRACHLOROETHYL CHLOROFORMATE; CARBON 11; CARBONIC ACID DERIVATIVE; CHLOROFORMIC ACID ETHYL ESTER; DOCETAXEL; TERT BUTYL 1,2,2,2 TETRACHLOROETHYL CARBONATE;

ARTICLE; DRUG SYNTHESIS; GOOD MANUFACTURING PRACTICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RADIOCHEMISTRY; REACTION ANALYSIS;

CARBON RADIOISOTOPES; ISOTOPE LABELING; RADIATION-SENSITIZING AGENTS; RADIOPHARMACEUTICALS; TAXOIDS;

EID: 48849109531     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2008.02.076     Document Type: Article

References (12)

1. Barcelo G., Senet J.P., and Sennyey G. 1,2,2,2-tetrachloroethyl tert-butyl carbonate - a simple and efficient reagent for the tert-butoxycarbonylation of amines and amino-acids. J. Org. Chem. 50 (1985) 3951-3953
2. Barcelo G., Senet J.P., and Sennyey G. Alkyl 1-chloroalkyl carbonates - reagents for the synthesis of carbamates and protection of amino-groups. Synthesis (1986) 627-632
3. Collins, J.M., Klecker, R.N., Anderson, L., 2001. Imaging of drug accumulation as a guide to antitumor therapy, WO/2001/021219.
4. Hudis C.A., Seidman A.D., Crown J.P.A., Balmaceda C., Freilich R., Gilewski T.A., Hakes T.B., Currie V., Lebwohl D.E., Baselga J., Raptis G., Gollub M., Robles M., Bruno R., and Norton L. Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer. J. Clin. Oncol. 14 (1996) 58-65
5. 11C]ethyloxy)carbonylamino)-2-phenylethyl)carbonyloxy]- (1S,2S,4S,7R,9S,10S,12R,15S)-1,9,12-trihydroxy-10,14,17,17-tetramethyl-4-(methylcarbonyloxy)-11-oxo-2-(phenylcarbonyloxy)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-ene.
6. Trudeau M.E., Eisenhauer E.A., Higgins B.P., Letendre F., Lofters W.S., Norris B.D., Vandenberg T.A., Delorme F., and Muldal A.M. Docetaxel in patients with metastatic breast cancer: a phase II study of the national cancer institute of Canada-clinical trials group. J. Clin. Oncol. 14 (1996) 422-428
7. Valero V., Holmes F.A., Walters R.S., Theriault R.L., Esparza L., Fraschini G., Fonseca G.A., Bellet R.E., Buzdar A.U., and Hortobagyi G.N. Phase-II trial of docetaxel -a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast-cancer. J. Clin. Oncol. 13 (1995) 2886-2894
8. Valerio M.R., Russo A., Latteri M.A., Modica G., Gulotta G., Armata M.G., Bajardi E., Cicero G., Pantuso G., and Grassi N. Weekly docetaxel as II line therapy in non-small cell lung cancer: an interim analysis of a phase II study. Lung Cancer 34 (2001) S31-S35
9. van der Meij M., Carruthers N.I., Herscheid J.D.M., Jablonowski J.A., Leysen J.E., and Windhorst A.D. Reductive N-alkylation of secondary amines with [2-C-11]acetone. J. Label Compd. Radiopharm. 46 (2003) 1075-1085
10. van der Meij M., Janssen C.G.M., Janssens F.E., Jurzak M., Langlois X., Sommen F.M., Verreet B., Windhorst A.D., Leysen J.E., and Herscheid J.D.M. Synthesis and biodistribution of [C-11]R116301, a promising PET ligand for central NK1 receptors. Bioorg. Med. Chem. 13 (2005) 1579-1586
11. van Tilburg E.W., Franssen E.J.F., van der Hoeven J.J.M., van der Meij M., Elshove D., Lammertsma A.A., and Windhorst A.D. Radiosynthesis of [C-11]docetaxel. J. Label Compd. Radiopharm. 47 (2004) 763-777
12. Windhorst A.D., Linden ter T., Nooij de A., Keus J.F., Buijs F.L., Schollema P.E., van Rooij L.F., and Herscheid J.D.M. A complete, multipurpose, low cost, fully automated and GMP compliant radiosynthesis system. J. Label. Compd. Radiopharm. 44 (2001) S1052-S1055